January 4, 2019
CAMBRIDGE, Mass. Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that it has received written confirmation from the U.S. Food and Drug Administration (FDA) regarding agreement on the design of its Phase 3 registration trials designed to evaluate light-activated AU-011 for the treatment of patients with choroidal...
Lund, Sweden, 8:00 CET, January 4 2019 – BONESUPPORT™ an emerging leader in Orthobiologics for the management of bone voids, announces changes in its leadership team that will take place March 1, 2019. Annelie Aava Vikner starts in a new position as the company´s Executive Vice President Global Marketing & Communications. Annelie Aava Vikner has...
January 3, 2019 Tiburio raises $31M in a Series A round to advance two clinical stage compounds TBR-760, for the treatment of nonfunctioning pituitary adenoma (NFPA), and TBR-065 for rare endocrine diseases Tiburio appoints Abraham N. Ceesay as Chief Executive Officer Cambridge, MA, January 3, 2019 – Cydan today announced the launch of Tiburio Therapeutics Inc....
Thanks to an ingenious technique – which is able to make tissue transparent – Danish researchers have discovered a ‘plumbing system’ that rids the brain of waste products. While we sleep. This is shown by new research recently published in the scientific journal Nature Neuroscience. The findings came to light in studies of the brains...
American startup Tiburio, which is in the process of developing a drug for rare tumours in the pituitary gland, receives more than DKK 200 million in investments – from Lundbeckfonden Ventures, among others. Lundbeckfonden Ventures and a number of other investors have invested a total of DKK 200 million in the newly launched Tiburio. The...


Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge